Pharmalot… Pharmalittle… A Holiday Weekend
Make a commentBy Ed Silverman // September 3rd, 2010 // 7:02 am
Good morning, everyone. How are you today? Slowing down just a bit, perhaps? Here in the states, of course, a three-day weekend is fast approaching. And so we will pull in the sidewalks early. We hope you have the opportunity to do the same. Meanwhile, here are a few nuggets to help you close out the week. Whatever you do over the next few days, may it be enjoyable. Cheers…
Celldex Says Pfizer Ends Cancer Vaccine Deal (Reuters)
Allergan Steps Up Overseas Clinical Trials (CBS News)
Novartis Experimental Malaria Drug May Be First In 30 Years (Bloomberg News)
Abbott Cancels Sale Of Solvay Vaccines Unit (The Wall Street Journal)
Accenture And ICRI Partner On Indian Clinical Research Training (Outsourcing Pharma)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Abbott Laboratories, Accenture, Allergan, Botox, Clinical Trials, India, Institute of Clinical Research in India, Malaries, Novartis, Solvay, Vaccines